Clinical Trial Update: Extension Study to Assess Long Term Safety in Children and Adolescents With Crohn's Disease Receiving Certolizumab Pegol [Phase 2]

View source ↗

Summary

extension study aimed at assessing long-term safety of certolizumab pegol in children and adolescents with Crohn's disease; completed with results posted in 20…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• Certolizumab pegol (certolizumab pegol)

Snippet

Sponsor: UCB Pharma | Conditions: Crohn's Disease | Phase 2 | Status: COMPLETED | Results posted: 2019-03-26